Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin |
Lee, Tae-Hee
(Department of Internal Medicine, Konyang University College of Medicine)
Lee, Kee-Ook (Department of Neurology, Konyang University College of Medicine) Kim, Yong-Seok (Department of Internal Medicine, Konyang University College of Medicine) Kim, Sun-Moon (Department of Internal Medicine, Konyang University College of Medicine) Huh, Kyu-Chan (Department of Internal Medicine, Konyang University College of Medicine) Choi, Young-Woo (Department of Internal Medicine, Konyang University College of Medicine) Kang, Young-Woo (Department of Internal Medicine, Konyang University College of Medicine) |
1 | Erickson S, Matikainen S, Thyrell L, et al. Interferon- alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes. Eur J Biochem 2002;269:29-37. DOI ScienceOn |
2 | Byrnes AA, Ma X, Cuomo P, et al. Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity. Eur J Immunol 2001;31:2026-2034. DOI |
3 | Lombardi G, Dunne PJ, Scheel-Toellner D, et al. Type 1 IFN maintains the survival of anergic CD4+ T cells. J Immunol 2000;165:3782-3789. DOI |
4 | Bani-Sadr F, Goderel I, Lapidus N, et al. Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin. AIDS 2008;22:1385-1387. DOI ScienceOn |
5 | Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. QJM 2000;93:245-251. DOI ScienceOn |
6 | Kauffman CA. Cryptococcosis. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia: Saunders, 2008:2347-2349. |
7 | Hultgren C, Milich DR, Weiland O, Sallberg M. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998;79:2381-2391. DOI |
8 | Shiffman ML, Verbeke SB, Kimball PM. Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytes. Antiviral Res 2000;48:91-99. DOI ScienceOn |
9 | Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002;36(5 Suppl 1):S237-S244. |
10 | Soza A, Everhart JE, Ghany MG, et al. Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology 2002;36:1273-1279. DOI ScienceOn |
11 | Cooper CL, Al-Bedwawi S, Lee C, Garber G. Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia. Clin Infect Dis 2006;42:1674-1678. DOI ScienceOn |
12 | Juarez-Navarro A, Vera-de-Leon L, Navarro JM, et al. Incidence and severity of infections according to the development of neutropenia during combined therapy with pegylated interferon-alpha2a plus ribavirin in chronic hepatitis C infection. Methods Find Exp Clin Pharmacol 2005;27:317-322. DOI ScienceOn |
13 | Puoti M, Babudieri S, Rezza G, et al. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther 2004;9:627-630. |
14 | Antonini MG, Babudieri S, Maida I, et al. Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. Infection 2008;36:250-255. DOI ScienceOn |
15 | Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E, Levitz SM. Cryptococcosis: clinical and biological aspects. Med Mycol 2000;38 Suppl 1:205-213. DOI ScienceOn |
16 | Netea MG, Brouwer AE, Hoogendoorn EH, et al. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy. Clin Infect Dis 2004;39:e83-e87. DOI ScienceOn |
17 | Vander T, Medvedovsky M, Hallevy C, Golzman G, Herishanu Y. Listeria monocytogenes meningitis in a patient with chronic hepatitis C infection, treated by interferon alfa and ribavirin. J Infect 2003;46:70-71. DOI ScienceOn |
18 | Hadem J, Cornberg M, Hauptmann C, Suttmann U, Manns MP, Wedemeyer H. Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C: do not miss vaccination before starting therapy. Z Gastroenterol 2008;46:880-882. DOI ScienceOn |
19 | Hoofnagle JH, Seeff LB. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006;355:2444-2451. DOI ScienceOn |
20 | Gutterman JU. Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci U S A 1994;91:1198-1205. DOI ScienceOn |
21 | Patterson JL, Fernandez-Larsson R. Molecular mechanisms of action of ribavirin. Rev Infect Dis 1990;12:1139-1146. DOI |
![]() |